IRINOTECAN Labatec 40 mg/2ml flac 2 ml

7680592840012 CH-59284 L01XX19 07.16.1.
IRINOTECAN Labatec 40 mg/2ml flac 2 ml
IRINOTECAN Labatec 40 mg/2ml flac 2 ml
IRINOTECAN Labatec 40 mg/2ml flac 2 ml
1 / 3
google

Details

Product number
5928401
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
irinotecani hydrochloridum trihydricum 40 mg, sorbitolum 90 mg, acidum lacticum, acidum hydrochloricum q.s. ad pH, natrii hydroxidum q.s. ad pH, aqua ad iniectabile ad solutionem pro 2 ml corresp. natrium 4.6 mg.

Articles (1)

Irinotecan Labatec 40 mg/2 ml, solution à diluer pour perfusion
Lösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
17/10/2024
Professional SmPC
Français
17/10/2024
Professional SmPC
Italien
17/10/2024

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
90.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
4.6 MG Substance HBESI

Reimbursement information

Public price
CHF 57.60
Specialties list
Yes
Generic
Yes
SL addition date: 01/04/2010

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
59284
Drug name
Irinotecan Labatec, solution à diluer pour perfusion
Galenic form
KOPA
ATC Code
L01XX19
Authorization status
Z
Dispensation category
A
First authorization
04/12/2009
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine

Packaging details

Description (FR)
IRINOTECAN Labatec 40 mg/2ml flac 2 ml
Description (DE)
IRINOTECAN Labatec 40 mg/2ml Durchstf 2 ml
Market launch
04/12/2009
Narcotic (BTM)
No

Other packaging sizes

IRINOTECAN Labatec 100 mg/5ml flac 5 ml
1 DUR
View
IRINOTECAN Labatec 300 mg/15ml flac
1 DUR
View